Advertisement

Topics

Therapeutic Touch - Biotech, Pharma and Life Science Channel

01:09 EST 22nd February 2017 | BioPortfolio

PubMed Articles [7196 Associated PubMed Articles listed on BioPortfolio]

Carbonic anhydrase inhibitory properties of some uracil derivatives.

Inhibitors of carbonic anhydrase (CA) have been carried out in many therapeutic applications, especially antiglaucoma activity. In this study, we investigated some uracil derivatives (4-12) to inhibit...

Anti-inflammatory and anticancer effects of flavonol glycosides from Diplotaxis harra through GSK3β regulation in intestinal cells.

Diplotaxis harra (Forssk.) Boiss. (Brassicaceae) is traditionally used as an antidiabetic, anti-inflammatory or anticancer agent. In these pathologies, the glycogen synthase kinase 3 β (GSK3β) is ov...

Transanal total mesorectal excision for a large leiomyosarcoma at the lower rectum: a case report and literature review.

Rectal leiomyosarcoma (LMS) is an extremely rare disease. Previously, LMS was not properly distinguishable from gastrointestinal stromal tumor (GIST) until c-kit, a characteristic marker of GIST, was ...

Priming increases the anti-tumor effect and therapeutic window of (177)Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1.

(177)Lu-[DOTA(0), Tyr(3)]-octreotate ((177)Lu-octreotate) is used for treatment of patients with somatostatin receptor (SSTR) expressing neuroendocrine tumors. However, complete tumor remission is rar...

Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients.

Cystic fibrosis (CF) is a genetic disease in which bacterial infections of the airways play a major role in the long-term clinical outcome. In recent years, a number of next-generation sequencing (NGS...

Comparison of some secondary metabolite content in the seventeen species of the Boraginaceae family.

The Boraginaceae family comprises plants that have important therapeutic and cosmetic applications. Their pharmacological effect is related to the presence of naphthaquinones, flavonoids, terpenoids, ...

Advance of autophagy in chronic kidney diseases.

Autophagy, a highly conserved mechanism for cell survival, emerges as an important pathway in many biological processes and diseases conditions. Studies of cultured renal cells, human kidney tissues a...

Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer with high incidence globally. Increasing mortality and morbidity rates combined with limited treatment options available ...

Nanocarriers as treatment modalities for hypertension.

Hypertension, a worldwide epidemic at present, is not a disease in itself rather it is an important risk factor for serious cardiovascular disorders including myocardial infarction, stroke, heart fail...

Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.

In the present study, we select the Sylysia 350 (Sylysia) as mesoporous material, distearoylphosphatidylethanolamine-poly(ethylene glycol)2000 (DSPE-PEG) as absorption enhancer and hydroxy propyl meth...

News Articles [2202 Associated News Articles listed on BioPortfolio]

BioSense Inks $68 Million Deal for Neovacs’ Autoimmune Disease Vaccine in China

New Jersey/Suzhou-based BioSense Global has signed an option agreement with Neovacs of France for Neovacs' Phase II-stage IFNα Kinoid therapeutic vaccine candidate, a treatment for lupus an...

Sangamo Therapeutics Announces Fourth Quarter And Full Year 2016 Conference Call And Webcast

RICHMOND, Calif., Feb. 21, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced today that the company will release its fourth quarter an...

NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Best Buy

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell® will be available in over 450 Best Buy® stores nationwide beginning in mid-February and is now available for purchas...

Surrozen Enters Regenerative Medicine Field with $33M Series A Financing

NewsThe funds will be used to implement a broad-based drug discovery platform aimed at unlocking the therapeutic potential of Wnt signaling.

Northwell Health, GE Ventures Form $200M Alliance to Develop, Commercialize Solutions in Bioelectronic Medicine

Today, GE Ventures announced a strategic partnership with Northwell Health’s Feinstein Institute for Medical Research providing up to $200 million in joint funding over seven years to support the op...

Medical tourism will help drive Indian pharma industry to reach $55 billion by 2020

The Indian pharmaceuticals market is expected to touch $55 billion by 2020 from $36.7 billion in 2016,…

Ferring Pharmaceuticals and Enteris BioPharma to develop an oral formulation of a Peptide-based Injectable Therapeutic

Biospectrum Enteris BioPharma will license to Ferring its oral drug delivery technologies, as well as provide clinical ...

InTouchMD Completes Secure Network Transport Connection to Webair’s NY1 Data Center to Ensure ePHI Security

Connectivity to Webair’s Interconnection Fabric at Its NY1 Facility Enables Secure and Private Consumption of Cloud Services Garden City, New York (PRWEB) February 21, 2017 InTouchMD, the leading p...

Scientists present the smallest member of the CRISPR-Cas9 family developed to date

Scientists at the Center for Genome Engineering, within the Institute for Basic Science (IBS), in collaboration with KIM Eunji (ToolGen Inc.) and KIM Jeong Hun (Seoul National University) have enginee...

U.S. patent for Urocortin 2 gene constructs issued

SAN DIEGO, Feb. 21, 2017 /PRNewswire-USNewswire/ -- Renova™ Therapeutics, a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes, announced today...

Events [0 Results]

None

Companies [344 Associated Companies listed on BioPortfolio]

RMEI Medical Education (RMEI)

Founded in 1990, RMEI Medical Education (RMEI) is one of the longest operating medical education companies in the U.S. With an emphasis on sophisticated learner analytics for prog...

Decibel Therapeutics

By combining recent innovations in hearing science with leading diagnostic tools, biological insights, modeling and therapeutic delivery techniques, Decibel is pioneering a compre...

Cambrooke Therapeutics, Inc.

Founded in 2000, Cambrooke is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with seriou...

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. ...

Rally Health, Inc.

Rally Health, Inc. helps people take an active role in their health care. We use clinical data, customized recommendations, and continual rewards to help users make positiv...

Kedrion Biopharma Inc.

Kedrion is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing se...

Ethris

Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the discovery, d...

Tandem Diabetes Care®, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commerciali...

SciFluor Life Sciences, Inc.

SciFluor Life Sciences is a drug discovery company developing a best-in-class portfolio of partnership-ready therapeutic drugs strategically capitalizing on the transformational p...

Xpertdoc Technologies Inc.

Xpertdoc Technologies Inc. is a global software company that provides industry-leading document generation and customer communications management (CCM) solutions. The company is a...

Clinical Trials [732 Associated Clinical Trials listed on BioPortfolio]

New Therapeutic Strategies for Inhibitory Control in Alcoholism

This experimental research studies the efficacy of two different treatments for inhibitory control improvement in alcohol-dependent individuals, one consisting of Retrieval-Extinction Lear...

Neurophysiological Impact of a Fronto-temporal tDCS Stimulation in Healthy Subjects: a Multimodal Imaging Approach

tDCS is a technique emerging as a prospective therapy for neurologic, psychiatric and addictive disorders. Specifically, fronto-temporal tDCS, with anodal stimulation over the left dorsola...

Effect of Paracetamol on Renal Function in Plasmodium Knowlesi Malaria

Acute kidney injury is a common complication of severe Plasmodium knowlesi malaria, and an important contributor to mortality. The exact pathogenic mechanisms of AKI in knowlesi malaria a...

The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's Disease

Here investigators will carry out this phase II clinical trial to explore a effective therapeutic regimen of MSC in the Crohn's perianal fistula.

A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease

This study is being conducted as an extension of the phase II clinical trial SRPL/CLI/10-11/001 (NCT01484574). The CDSCO has recommended flexibility for continued clinical study in consult...

Clinical Effects of Ozone Therapy in Cervical Disc Hernia

The aim of the study is to evaluate the clinical effects of Ozone-oxygen therapy as therapeutic substance for nucleolysis application in the patients with cervical disc hernia who had chro...

Multicentric Retrospective Prognostic Evaluation of Tumor Volume and Their Changes in Radical Radiotherapy of Locally Advanced NSCLC

The aim of the study is to retrospectively monitor the 'gross tumor volume' (GTV) before initiation of radiotherapy and its changes during radiotherapy and to correlate them with retrospec...

Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis

Mepolizumab is a humanized Immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that acts on Interleukin-5 (IL-5), which is responsible for the growth and differentiation, recruitment, activ...

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

This study will test the feasibility of using novel/existing imaging technologies focused on hypoxia measurements to determine "response to therapy" in pediatric soft tissue sarcomas as a ...

Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer

This clinical trial studies how well helical computed tomography (CT), positron emission tomography (PET)/CT, magnetic resonance imaging (MRI), and cone beam computed tomography (CBCT) wor...

Videos

None available.

Medical and Biotech [MESH] Definitions

Loss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities.

Perception of shape and form of objects by TOUCH, via tactile stimuli.

Stiff hairs projecting from the face around the nose of most mammals, acting as touch receptors.

Placing of the hands of the healer upon the person to be cured with the intent of spiritual energetic healing.

Sensation of making physical contact with objects, animate or inanimate. Tactile stimuli are detected by MECHANORECEPTORS in the skin and mucous membranes.

Quick Search
Advertisement
 
review and buy Therapeutic Touch market research data and corporate reports here

Channels Quicklinks